Infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable disease.
about
Neurological Disorders Associated with Striatal Lesions: Classification and Diagnostic Approach.The spectrum of pyruvate oxidation defects in the diagnosis of mitochondrial disorders.Emerging aspects of treatment in mitochondrial disorders.A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders.Treatment of genetic defects of thiamine transport and metabolism.Free-thiamine is a potential biomarker of thiamine transporter-2 deficiency: a treatable cause of Leigh syndrome.Potential Role of Genomic Sequencing in the Early Diagnosis of Treatable Genetic Conditions.Early Infantile Leigh-like SLC19A3 Gene Defects Have a Poor Prognosis: Report and Review.Compound heterozygous SLC19A3 mutations further refine the critical promoter region for biotin-thiamine-responsive basal ganglia disease.Treatable mitochondrial diseases: cofactor metabolism and beyond.Reply: Infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable disease.Biotin-thiamine responsive basal ganglia disease: Identification of a pyruvate peak on brain spectroscopy, novel mutation in SLC19A3, and calculation of prevalence based on allele frequencies from aggregated next-generation sequencing data.Mitochondriopathien – neue Trends in Diagnostik und Therapie
P2860
Q31076462-A51C38AF-C522-4943-987F-A89B1A271103Q38294904-37D4B2C7-BDA6-4C70-BD1A-389E40872527Q38472989-4BDB4F8D-4B77-41FF-ABC1-3302C370F109Q38802675-8A7D0EA6-C210-462B-BCA6-CB933B716350Q38837368-50EB0081-F14C-4D32-97E8-E5AF604551C7Q42486103-702B1A54-D49A-4311-96EE-91E5214CB42CQ44243273-09AC0155-8985-42AA-A7BB-2300B6459E01Q45965170-A546CC71-67C8-460E-9978-BC327C01E2A9Q47139687-DE1E1A58-88EC-409D-B05B-9E4ACCDFE1EDQ48390229-415837DF-4ED5-4C36-99D1-DD3609B0939FQ48750034-CA9D597F-3340-4EA6-B765-4F42FAFE9F57Q52098860-D4FD6632-5323-49A8-A32E-5DC155C5491BQ57251779-64A4306A-6F4E-4E9A-8FE0-74D5BC390FF9
P2860
Infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable disease.
@en
Infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable disease.
@nl
type
label
Infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable disease.
@en
Infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable disease.
@nl
prefLabel
Infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable disease.
@en
Infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable disease.
@nl
P2093
P2860
P356
P1433
P1476
Infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable disease.
@en
P2093
Ertan Mayatepek
Felix Distelmaier
Tim M Strom
Tobias B Haack
P2860
P356
10.1093/BRAIN/AWU128
P407
P577
2014-05-30T00:00:00Z